Loading stock data…
SLP
$16.11+0.10 (+0.62%)
Market OpenUpdated 2:54 PM EDT
Simulations Plus, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Simulations Plus, Inc. in the Healthcare sector is trading at $16.11. Wall Street consensus targets $23.67 (3 analysts), implying a +46.9% move over the next 12 months. The stock is currently 42% below its 52-week high of $27.67, remaining 3.1% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +46.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $24.29M↑ | $18.42M↑ | $17.46M↓ | $20.36M↓ | $22.43M |
| Gross Profit | $16.14M↑ | $10.89M↑ | $9.84M↓ | $13.03M↓ | $13.13M |
| Operating Income | $5.63M↑ | $713,000↑ | $659,000↓ | $3.00M↑ | $2.71M |
| Net Income | $4.54M↑ | $676,000↑ | -$681,000↑ | -$67.32M↓ | $3.07M |
Peer Comparison
JNJUNHPFE
Fundamentals
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Softwar...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-46.94%
Volume
Today's trading volume
69,487
Recent News
Is It Too Late To Consider Buying Simulations Plus, Inc. (NASDAQ:SLP)?
While Simulations Plus, Inc. ( NASDAQ:SLP ) might not have the largest market cap around , it saw a significant share...
This Analyst Just Made A Huge Upgrade To Their SLP Resources Berhad (KLSE:SLP) Earnings Forecasts
Celebrations may be in order for SLP Resources Berhad ( KLSE:SLP ) shareholders, with the covering analyst delivering a...
Do Options Traders Know Something About Simulations Plus Stock We Don't?
Investors need to pay close attention to SLP stock based on the movements in the options market lately.
Badger Meter's Q1 Earnings & Revenues Miss Estimates, Stock Dips
BMI misses Q1 estimates as sales fall 9% on project delays, but a strong pipeline and UDlive acquisition signal confidence in long-term growth.
Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development
Simulations Plus Inc (NASDAQ:SLP) is among the best medical AI stocks to buy now. On March 26, Simulations Plus announced collaboration programs for AI-enabled modeling in drug development. Simulations Plus uses AI to help scientists increase efficiency in their modeling workflow. The company said three large pharmaceutical companies were participating in its collaboration programs. Back […]